Breast Cancer

In 2014, Novartis Oncology commissioned the Harris Poll to conduct the Make Your Dialogue Count survey to identify the emotional needs of patients newly diagnosed with metastatic breast cancer as well as during treatment change.

An oncology nurse's overview of inflammatory breast cancer.

A recent study shows CDK inhibitor ribociclib reduces progression of HR-positive metastatic breast cancer.

A recent survey found that 77% of working women with breast cancer, including those with metastatic disease, feel that working aids in their recovery.

Genevieve's Helping Hands looks to help make the cancer journey easier to navigate, provide an arm to lean on, and offer encouragement when needed.

The American Breast Cancer Foundation's (ABCF) mission is to provide financial assistance for breast cancer screenings and diagnostic tests for uninsured and underserved individuals, regardless of age or gender.

The treatment of TNBC is rapidly evolving, with immotherapies, AR-targeted agents and targeted therapies.

Dense breast tissue can make tumors more difficult to spot in mammograms. And extremely dense tissue may be an independent risk factor for developing breast cancer.

Molly Olm-Shipman talks about how a nurse can help ensure that the autonomy of patients with breast cancer is preserved.

Mary Ellen Diotalevi speaks about her role as a nurse in a breast cancer center.

Ricardo Bello, MD, MPH, discusses what patients with breast cancer need to be aware of to make informed decisions after mastectomy.

Dr. Killelea talks about the importance of communication between all healthcare providers when treating patients with breast cancer.

African American breast cancer survivors experience some specific concerns and risk factors that healthcare practitioners should be aware of when developing survivorship care plans for this population.

Using integrative modalities such as behavior therapies, mindfulness meditation and creative arts therapy can support a patient with cancer during treatment.

Deborah Derman used her personal losses and professional experiences to create the new book Colors of Loss and Healing: An Adult Coloring Book for Getting Through Tough Times to help people move forward in their lives.

MammaPrint has been shown to improve prediction of clinical outcomes in women with early-stage breast cancer.

A large, population-based study found that obesity more prevalent in patients with a history of cancer than in the general population, suggesting an important area of focus and a need for improved weight management and control programs targeted at survivors’ specific needs.

METAvivor is dedicated to the specific fight of women and men living with stage 4 metastatic breast cancer.

Kathryn H. Schmitz, PhD, MPH, professor of Public Health Sciences and associate director of Population Sciences at the Penn State Cancer Institute, discusses benefits that can be reaped from running parallel mouse and human studies.

A study has found that telephone cancer genetic counseling can be just as effective as in-person counseling for women at risk for hereditary breast and ovarian cancer

Tara Sanft, MD, Yale Cancer Center, discusses decreasing VEGF levels through exercise and diet to prevent breast cancer recurrence.

New practice guideline now recommends a 2-mm margin width as the standard for patients with DCIS undergoing breast-conserving surgery.

Breast cancer is the leading cause of cancer deaths among Black women of all ages and is increasing in younger women in the U.S.

What do patients think about being tested for many genes that may impact their hereditary risk for breast or ovarian cancer, beyond the well-known BRCA mutations?

A study involving women with a BRCA mutation who had risk-reducing surgery to lower their risk of breast and/or ovarian cancer found that many of these individuals have surgical procedures such as oophorectomy or mastectomy without a full understanding of how they will affect their sexuality and other aspects of their lives.

The field of breast cancer has evolved from the days of defaulting to chemotherapy for every patient, yet much work remains to individualize treatment. Though more promising novel regimens have become available, an expert urges clinicians to carefully weigh whether a particular new agent will provide a significant enough benefit to offset its associated toxicities, cost, and the time and commitment by the patient it requires.

Hope S. Rugo, MD, professor of Medicine and director of breast oncology and clinical trials education at the UCSF Helen Diller Family Comprehensive Cancer Center, discusses DigniCap, a scalp cooling device to prevent chemotherapy-induced hair loss.

Many risk factors for breast cancer have been identified. One suspected risk factor is in vitro fertilization (IVF) treatment; however, several studies have been inconclusive because of limited follow-up.